- Home
- IMNM vs MRC Comparison
IMNM vs MRC Comparison
Compare IMNM & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- MRC
- Stock Information
- Founded
- IMNM 2006
- MRC 1921
- Country
- IMNM United States
- MRC United States
- Employees
- IMNM N/A
- MRC N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- MRC Industrial Machinery/Components
- Sector
- IMNM Health Care
- MRC Industrials
- Exchange
- IMNM Nasdaq
- MRC Nasdaq
- Market Cap
- IMNM 987.1M
- MRC 1.1B
- IPO Year
- IMNM 2020
- MRC 2012
- Fundamental
- Price
- IMNM $13.83
- MRC N/A
- Analyst Decision
- IMNM Strong Buy
- MRC Strong Buy
- Analyst Count
- IMNM 9
- MRC 3
- Target Price
- IMNM $24.89
- MRC $16.00
- AVG Volume (30 Days)
- IMNM 2.0M
- MRC 863.0K
- Earning Date
- IMNM 11-12-2025
- MRC 11-04-2025
- Dividend Yield
- IMNM N/A
- MRC N/A
- EPS Growth
- IMNM N/A
- MRC N/A
- EPS
- IMNM N/A
- MRC N/A
- Revenue
- IMNM $12,589,000.00
- MRC $2,945,000,000.00
- Revenue This Year
- IMNM N/A
- MRC $5.81
- Revenue Next Year
- IMNM $154.70
- MRC $5.43
- P/E Ratio
- IMNM N/A
- MRC N/A
- Revenue Growth
- IMNM 16.74
- MRC N/A
- 52 Week Low
- IMNM $5.15
- MRC $9.23
- 52 Week High
- IMNM $15.13
- MRC $15.59
- Technical
- Relative Strength Index (RSI)
- IMNM 67.38
- MRC 49.34
- Support Level
- IMNM $11.25
- MRC $14.20
- Resistance Level
- IMNM $12.00
- MRC $15.35
- Average True Range (ATR)
- IMNM 1.01
- MRC 0.41
- MACD
- IMNM 0.40
- MRC -0.00
- Stochastic Oscillator
- IMNM 87.06
- MRC 31.97
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About MRC MRC Global Inc.
MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.